LM-10


CAS No. : 1316695-35-8

LM-10,1316695-35-8
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000006
Synonyms:LM 10
Molecular Formula:C11H8FN5
Molecular Weight:229.21
Target:Tryptophan 2,3-dioxygenase Inhibitor
IC50:0.62 and 2 μM for human and mouse TDO
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

refresh
Appearance:Solid powder
Purity: > 98%
Cat No:I000006
Cas No:1316695-35-8
Product-Name:LM-10
InChI:InChI=1S/C11H8FN5/c12-8-2-3-9-7(6-13-10(9)5-8)1-4-11-14-16-17-15-11/h1-6,13H,(H,14,15,16,17)/b4-1+
InChIKey:JDBSZVDIUIRSDG-DAFODLJHSA-N
SMILES:FC1=CC2=C(C=C1)C(/C=C/C3=NN=NN3)=CN2
LM-10(cas 1316695-35-8) is a selective tryptophan 2,3-dioxygenase (TDO) inhibitor (IC50 values are 0.62 and 2 μM for human and mouse TDO, respectively).
1:Exp Neurol. 1996 Sep;141(1):47-56. The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS: (II). Microencapsulated CSF-1 and LM-10 cells as delivery systems.Maysinger D,Berezovskaya O,Fedoroff S, PMID: 8797667 DOI: 10.1006/exnr.1996.0138
Abstract: The aim of this study was to develop delivery systems for administration of CSF-1 to remedy the systemic deficiency of this cytokine in osteopetrotic op/op mice and to study the microglial response and neuronal survival in op/op mice following cerebral cortex ischemic lesion. Unilateral cerebral cortex ischemic lesions were produced in homozygous op/op mice and either microencapsulated rhCSF-1 or LM-10 fibroblast-like cells producing CSF-1 were administered either locally, at the site and time of the lesioning, or into the peritoneum 2 weeks before the lesion was made. Physical properties (shape, size, integrity) and kinetics of rhCSF-1 release were assessed prior to the experiments in situ. Depending on the characteristics of the biodegradable polymer (e.g., chitosan with different densities or poly-L-lactic-poly-glycolic acid), remarkable differences in survival of encapsulated cells were observed. Cellular integrity following encapsulation and metabolic activity was regularly assessed for a period of 1 month. The best level of viability was achieved with highly viscous chitosan (311). The results from these studies demonstrate that: (1) rhCSF-1 incorporated into biodegradable spheres can be released and retain its biological activity; (2) microencapsulated LM-10 cells which produce CSF-1 can survive and constitutively release CSF-1 in alginate-chitosan spheres for different lengths of time depending on the physical properties of the chitosan used; and (3) CSF-1 is an important growth factor in the central nervous system where it can both strongly alter morphological changes of microglia and enhance survival of neurons in injured brain.
Recommended Products
  • CAS No. :145300-01-2
    Product Name:

    3-Cyclohexen-1-one, 5-acetyl-4-methyl- (9CI)

    Cat No: M099925 View details
  • CAS No. :148017-28-1
    Product Name:

    N-(tert-Butoxycarbonyl)sulfamide

    Cat No: M099926 View details
  • CAS No. :142702-33-8
    Product Name:

    B-L-FUCOPYRANOSYLPHENYL ISOTHIOCYANATE

    Cat No: M099928 View details
  • CAS No. :154750-32-0
    Product Name:

    5,5-DIMETHYL-3-(THIOCYANATOMETHYL)DIHYDRO-2[3H]-FURANONE

    Cat No: M099931 View details